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536Objectives: Autograft dilatation is leading to an increase in root reoperations late after the Ross procedure.
A 14-year clinical experience was reviewed to define the feasibility and outcome of the autograft valve–sparing
root reoperation.
Methods: One hundred twenty-six patients surviving an average of 7.4  9.9 years after the Ross procedure
underwent cross-sectional clinical and echocardiographic examination. Study end points were freedom from
autograft dilatation (diameter>4 cm or 2.1 cm/m2), root reoperation, root replacement, and functional outcome
after the valve-sparing reoperation.
Results: Thirty-one (25%) patients had dilatation, with 45% 9% freedom at 14 years. In 14 (11%) patients an
autograft aneurysm (>5.0 cm) was found: 12 had reoperations at 8.9  2.6 years after the Ross procedure. Risk
factors for root reoperation at multivariate analysis were root technique (P ¼ .01), root dilatation (P¼ .001), and
follow-up duration (P¼ .06). Two patients had root replacement, and 10 (83%) had remodeling with valve pres-
ervation (8 Yacoub procedures and 2 sinotubular junction/ascending aorta procedures); all survived reoperation.
Absence of severe autograft insufficiency (P ¼ .04) and convergent-type aneurysm (P ¼ .05) were associated
with successful valve preservation. Fourteen-year freedom from root reoperation was 80%  7%, and freedom
from full root replacement was 97%  4%. At 3.2  1.5 years (range, 0.2–4.8 years) after root reoperation, all
patients are in New York Heart Association class I and are medication free: 9 of 10 patients have mild autograft
valve insufficiency or less, and 1 required valve replacement 51 months after remodeling. One patient carried out
2 uncomplicated pregnancies 3 and 4 years after the Ross–Yacoub procedure.
Conclusions: Root reoperation with pulmonary valve preservation is feasible in the majority of patients with
autograft aneurysms, allowing for maintenance of normal quality of life. Referral of patients with a dilated
root before the appearance of severe valve insufficiency increases the likelihood of pulmonary valve sparing.
Functional behavior of remodeled autograft roots is rewarding; however, continued observation is warranted.
(J Thorac Cardiovasc Surg 2010;139:536-42)Forty years after introduction into clinical practice, the Ross
procedure is experiencing declining fortune.1 Although in-
cremental morbidity caused by allograft repair of the right
side of the heart was partly expected,2 late complications re-
lated to emerging autograft root and valve pathology were
mostly unforeseen.3-5 In fact, root dilatation with or without
valve dysfunction has clearly turned into the Achilles’ heel
of the Ross procedure, exceeding by far the prevalence
and severity of right-sided valve dysfunction.1,4,5
Several strategies have been proposed to deal with auto-
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The Journal of Thoracic and Cardiovascular Surgavoidance3,6 or support of the root technique,7 b-blocker
therapy, and, when required, elective root replacement4,8
or remodeling with pulmonary valve preservation.8-13 Be-
cause only the latter option has the potential to respect the
‘‘Ross paradigm’’ (ie, to guarantee a living, autologous
valve allowing normal quality of life), a systematic approach
was prospectively adopted at our institution that entails elec-
tive root remodeling (the Ross–Yacoub procedure) accord-
ing to criteria proposed for native aortic aneurysms in
patients with a bicuspid aortic valve.14 The results with
such a strategy are reported.
MATERIALS AND METHODS
Institutional review board approval was obtained for the conduct of this
study, and the board waived the need for patient consent.
Patients
Between May 1994 and November 2008, 129 consecutive patients (108
male and 21 female patients aged 22.3 17.3 years [range, 0.08–49 years])
underwent the Ross procedure at our institution. Indication for surgical in-
tervention was valve insufficiency in 80 (62%) patients, stenosis in 18
(14%) patients, or mixed lesion in 31 (24%) patients; 90 (70%) patients
had a bicuspid valve, and 24 (19%) patients had an aneurysmal (diameterery c March 2010
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FIGURE 1. Actuarial freedom from root dilatation in 126 long-term survi-
vors after the Ross procedure. Error bars represent  standard deviations.
Patients at risk are reported over the x-axis.
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D>5 cm) ascending aorta or aortic root. Twenty (16%) patients had under-
gone 1 or more prior operative cardiac procedures (aortic valvotomy,
n ¼ 10; balloon valvuloplasty, n ¼ 5; coarctation repair, n ¼ 6; subaortic
obstruction relief, n ¼ 3; and ventricular septal defect repair, n ¼ 2).
Ross Procedure Technique
Three operative techniques were used to implant the autologous pulmo-
nary valve in the aortic position: subcoronary grafting (26 patients), inclu-
sion cylinder (43 patients), and free-standing root replacement (60
patients), according to techniques described elsewhere.5 Freestanding root
replacement was the technique of choice in children (<18 years), whereas
inclusion cylinder and subcoronary grafting were preferred in adults. The
latter 2 were applied nonrandomly, with variable frequency over time:
subcoronary grafting was historically the first technique used and has re-
turned to be the preferred one nowadays. Routine buttressing of inflow
(annular) and outflow (ascending aortic) suture lines with strips of glutaral-
dehyde-fixed autologous pericardium was abandoned after 1998. Associ-
ated procedures were performed in 24 patients, including reductive
tailoring aortoplasty in 19 patients and ascending aortic replacement in 2 pa-
tients, all with aortic aneurysms, and repair of membranous ventricular sep-
tal aneurysm, repair of atrial septal defect, and coronary artery bypass
grafting, each in 1 patient, respectively.
Clinical Follow-up
In the present cross-sectional follow-up study (median, 6.7 years; range,
0.5–14.6 years), all 126 late survivors (100%) were assessed by means of
direct physical examination at our clinic (n¼ 98) in conjunction with echo-
cardiographic evaluation or by means of telephone interview (n ¼ 28). Pa-
tients who were suspected to have aneurysmal dilatation of the aorta
(diameter>5 cm) at echocardiographic examination underwent concomi-
tant magnetic resonance imaging of the chest and yearly imaging thereafter.
Echocardiographic Data and Measurements
All patients underwent transthoracic echocardiographic examinations at
discharge and were scheduled for repeat examinations on a yearly basis
thereafter. The same experienced sonographer at our institution undertook
cross-sectional follow-up echocardiographic investigation or reviewed ex-
aminations performed elsewhere to eliminate interobserver variability. Au-
tograft dimensions were measured as previously described5 at 4 different
levels: (1) aortoventricular junction (aortic annulus), (2) sinus of Valsalva,
(3) sinotubular junction, and (4) proximal ascending aorta. Aortic insuffi-
ciency was graded with the use of standard criteria.5
Technique of Reoperation
During the early stage of the experience, indication for reoperation on the
aortic root was deferred until the aorta exceeded 5.0 to 5.5 cm and the au-
tograft valve showed at least moderate regurgitation. Subsequently, the cri-
terion proposed for elective aortic root operations in patients with Marfan
syndrome or bicuspid aortic valve disease14 was prospectively adopted.
This criterion recommends elective aneurysmal resection when the aortic
cross-sectional area (r2p) indexed to body height exceeds 10.14 Preventive
dissection of femoral vessels for peripheral cardiopulmonary bypass was
performed in all patients before repeat sternotomy. Autograft valve sparing,
either by means of remodeling of the sinotubular junction (ascending aortic
aneurysm) or aortic root remodeling (aortic root aneurysm) with a modified
Yacoub procedure, was the intended treatment in all patients. Competence
of the autograft valve at the end of aneurysm repair was tested by using in-
traoperative transesophageal echocardiographic analysis. Conversion to
valve replacement during a second period of cardiopulmonary bypass and
cardiac arrest was performed when residual autograft valve insufficiency
was graded as moderate or greater. As a reference during the same time in-
terval (1994–2008), 158 native aortic valve–sparing procedures (138
Yacoub remodeling and 20 David I reimplantation procedures) were
performed at our institution.The Journal of Thoracic and CaStatistical Analysis
Categorical variables are reported as absolute numbers and percentages.
Continuous variables are expressed as means  standard deviations. Time-
related events were described by using the Kaplan–Meier estimate and com-
paredwith the log-rank test. Primary end points of the studywere as follows:
freedom from autograft dilatation (root diameter>4 cm or 0.21 cm/m2 at
any of the 4 levels examined), freedom from any reoperation on the auto-
graft, freedom from reoperation on the autograft root, and freedom from re-
placement of the autograft root. Secondary end points were the clinical and
functional status of patients after root remodeling. Univariate analysis was
performed to identify factors predictive of a need for root reoperation and of
the success of root remodeling with valve preservation. Multivariate analy-
sis was performed by using a multiple logistic regression method to identify
risk factors for time-related occurrence of autograft dilatation and root reop-
eration. Variables entered in the analysis included age at the time of the Ross
procedure, sex, body surface area, diagnosis (regurgitation, stenosis, and
mixed), bicuspid aortic valve, prior aortic procedure, operative technique
(subcoronary, cylinder inclusion, and root replacement), use of pericardial
strips, associated procedure, length of follow-up, aneurysm (diameter>5
cm or 2.6 cm/m2) of the sinus of Valsalva, sinotubular junction or ascending
aorta before and after the Ross procedure, grade of autograft valve regurgi-
tation, and morphology of the aortic aneurysm before reintervention (clas-
sified as tubular, convergent, or divergent). The SAS software (release
9.1; SAS Institute, Inc, Cary, NC) was used for statistical analysis. A com-
prehensive review of all reported cases of autograft root remodeling with
valve preservation and of root replacement4,8-12,15-23 was also undertaken.RESULTS
Survival
Hospital mortality for the entire clinical series was 1.5%:
both patients died of a cardiac cause. Patients were followed
for an average of 7.4  9.9 years (range, 0.5–14.6 years).
One late sudden death was recorded 1 year after surgical in-
tervention, resulting in an overall survival of 98%  1% at
14 years. The 126 long-term survivors constitute the focus of
the present study.Autograft Dilatation
Dilatation at 1 or more of the autograft levels was encoun-
tered in 31 (25%) patients: freedom from dilatation was
45%  9% at 14 years (Figure 1). The prevalence of auto-
graft dilatation was higher among patients undergoing therdiovascular Surgery c Volume 139, Number 3 537
TABLE 1. Variables associated with aortic root dilatation
Odds ratio 95% CI P value
Root technique 2.75 0.77–9.86 .001
Follow-up after
the Ross operation
1.28 0.30–5.44 .002
CI, Confidence interval.
TABLE 2. Variables associated with aortic root reoperation
Odds ratio 95% CI P value
Root dilatation 7.49 0.99–22.55 .001
Root technique 2.54 1.40–9.72 .01
Follow-up after
the Ross operation
1.27 0.91–1.59 .06
CI, Confidence interval.
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(14%) of 43 having inclusion cylinders and 1 (4%) of 25
having subcoronary implants (root vs inclusion or subcoro-
nary, P ¼ .004). Multivariate analysis showed use of a root
replacement technique (P ¼ .001) and length of follow-up
(P¼ .002) as risk factors for dilatation (Table 1). Among pa-
tients with dilatation, aneurysmal diameter was identified in
14 (11%; 12 male and 2 female patients) at a mean time of
7.7 2.8 years (range, 4.3–13.6 years) after the Ross proce-
dure: 12 had root reoperation, as described below, and 2 are
awaiting elective operations.Autograft Root Reoperation
During the study period, 18 patients underwent a total of
22 cardiac procedures, with no hospital mortality: freedom
from any cardiac reoperation was 77%  5% at 14 years
for the entire Ross series. Among these, 12 (67%) patients
required an autograft root reoperation at an average of
8.9 2.6 years (range, 6.1–14.3 years) after the original op-
eration. All but 1 (cylinder inclusion) had undergone auto-
graft root replacement. Univariate analysis identified
younger age at the time of the Ross procedure (P ¼ .01),
a history of prior cardiac surgery (P ¼ .02), use of a root re-
placement technique (P ¼ .01), autograft dilatation (P ¼
.001), and length of follow-up (P ¼ .002) as risk factors
for root reoperation. The latter 3 risk factors proved signifi-
cant also at multivariate analysis (Table 2). Root reoperation
was planned electively in 11 patients and on an emergency
basis in 1 patient who experienced acute autograft root dis-
section.13 At the time of the operation, severe pathology of
the sinus and sinotubular and ascending aortic segments
with normal-appearing pulmonary valve leaflets, as repre-
sented in Figure 2, was a rather constant finding. Root re-
modeling with valve preservation by using the Yacoub
technique in 10 patients and sinotubular junction remodeling
with ascending aortic replacement in 2 patients proved suc-
cessful in 10 (83%) root reoperations. In the first 2 patients
of the series, both with severe autograft regurgitation, satis-
factory competence of the valve could not be obtained after
Yacoub remodeling, leading to full root replacement. There
was no hospital mortality after root reoperation. Histologic
findings of the excised pulmonary autograft roots showed
moderate-to-severe elastic fiber fragmentation in all, mild
cystic medial necrosis in 5 patients, severe cystic medial ne-
crosis in 1 patient with dissection, fibrosis of media and ad-
ventitia in 7 patients, and increased intimal thickness in 8538 The Journal of Thoracic and Cardiovascular Surgpatients. Fourteen-year freedom from any root reoperation
was 80%  7%, whereas freedom from full root replace-
ment was 97%  4% (P ¼ .01, Figure 3). Among the 10
patients having successful valve preservation, 1 eventually
required valve replacement, as reported below. Univariate
analysis showed larger root diameters (P ¼ .05), absence
of severe autograft valve insufficiency (P ¼ .04), and con-
vergent-type aneurysms (P ¼ .05) to be more common
among patients having successful valve-sparing root reoper-
ations (Table 3).Functional Outcome After Valve-Sparing
Reoperation
Patients were followed for an average of 3.2  1.5 years
(range, 0.2–4.8 years), and only 1 patient, who required re-
operation, experienced adverse cardiovascular events. Age
at follow-up was 33.0  10.7 years, ranging from 21.5 to
55.5 years; all patients were in New York Heart Association
class I and free of cardiac medications, including warfarin.
Eight patients were employed full-time, and 2 were complet-
ing university education. All performed regular exercise,
and 3 engaged in strenuous sports. One woman, who was
28 years old at the time of the redo operation, carried out
2 successful pregnancies with cesarean section delivery 3
and 4 years after the Yacoub procedure, respectively. Fol-
low-up echocardiographic assessment, which was available
in all patients, showed trivial residual valve regurgitation in
7 patients, mild residual valve regurgitation in 2 patients,
and severe residual valve regurgitation in the 1 patient
who had presented with dissection and required aortic valve
replacement 4.3 years after the Yacoub procedure.DISCUSSION
This study adds further evidence to numerous other obser-
vations showing that autograft root dilatation with or without
valve dysfunction is the most taxing adverse event late after
the Ross procedure.1,3-5,17,20-24 This is particularly true when
the operation is performed as a root replacement technique.
Ironically, the very same modification to the original Ross
procedure that made it readily reproducible and thus highly
popular in the 1990s has nowadays turned into the reason for
the vanishing enthusiasm for this elegant procedure.1
In addition, the current study suggests that a policy of re-
section of autograft root aneurysms based on standardized
criteria can be associated with a high rate of pulmonary valveery c March 2010
FIGURE 2. Intraoperative view of the autograft root in a patient undergoing root remodeling with valve preservation (Ross–Yacoub procedure). A, The
ascending aorta has been transected at the level of the original autograft–aorta anastomosis. Three stay sutures have been placed at the valve commissures,
and the leaflets were retracted to expose the left ventricular outflow tract. Marked dilatation of the sinus of Valsalva segment is apparent. B, Same view as A,
only with the autograft valve in the closed position. The leaflets are normal looking, and coaptation is preserved. C, The autograft root has been entirely ex-
cised, except for a thin rim of tissue at the left ventricular–autograft junction (annulus). The harvested coronary buttons are also visible. D, completed repair
after Dacron vascular graft implantation.
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surgery. This strategy, herein arbitrarily named the Ross–
Yacoub procedure, allows the Ross paradigm, with its atten-
dant excellent quality of life, to live on.
Autograft Dilatation
The prevalence of dilatation in the present analysis was
somewhat lower than previously reported by our group
(25% vs 34%); however, the proportion of patients having
root aneurysms caused by progression increased 3-fold
(11% vs 4%).3 Explanations might include a shift from
root replacement to the subcoronary grafting technique in
the last 6 years of practice, application of strict criteria for
patient selection (conversion to alternative prosthetic
devices in case of even slight geometric mismatch of aor-
tic–pulmonary roots), and growing satisfaction with native
aortic valve repair, with root remodeling when required, in
young patients with regurgitant bicuspid valves. The latter
has become the treatment of choice for these patients, who
constitute the largest group in the present and other RossThe Journal of Thoracic and Caseries yet also those at greater risk for late failure.1,3,4,20,22,23
Practically, this has resulted in a 3-fold decrease in the num-
ber of Ross procedures performed yearly at our center (from
an average of 15 to 5). The present study confirms prior work
by Sievers and associates6 showing that dilatation is rare in
patients undergoing subcoronary implantation. Further-
more, it shows that dilatation is uncommon (14%) and gen-
erally stable in patients undergoing cylinder inclusion yet
highly prevalent and often progressive in those undergoing
autograft root replacement. Indeed, the latter variable, as
well as length of follow-up, continues to prove to be associ-
ated with dilatation at multivariate analysis, as previously
observed.5,23,24 Comparison with prior studies is hampered
by the paucity of series comparing the 3 operative tech-
niques.3,7,16,23 Nonetheless, the observation that both the
prevalence of root dilatation and freedom from root dilata-
tion in Ross series exclusively using the root technique are
strikingly similar to the results herein corroborates the effect
of the operative technique.1,3,4,20-24 On the contrary, the pre-
viously reported protective effect conferred by pericardialrdiovascular Surgery c Volume 139, Number 3 539
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FIGURE 3. Actuarial freedom from root reoperation (dashed line) and
from full root replacement (solid line) in 126 long-term survivors after the
Ross procedure. Error bars represent  standard deviations. Patients at
risk are reported over the x-axis.
TABLE 3. Variables associated with successful valve preservation
Valve
preservation
(n ¼ 10)
Valve
replacement
(n ¼ 2)
P
value
Root diameter before
root redo (mm)
56  4 52 .05
Severe AI before root redo 1 2 .04
Convergent-type aneurysm
before root redo
7 0 .05
AI, Autograft valve insufficiency.
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did not emerge at extended follow-up. This might reflect
the inability of annular and sinotubular junction support to
prevent sinus of Valsalva dilatation (convergent aneurysm),
as reported by Kouchoukos and colleagues,4 which repre-
sents the typical pattern of pathologic remodeling of free-
standing autograft roots.4,5Autograft Root Reoperation
Overall freedom from any cardiac reoperation in the cur-
rent series was comparable with that seen in most other long-
term (>10 years) follow-up series, including 69% at 13
years reported by Klieverik and coworkers,1 75% at 10
years reported by Kouchoukos and colleagues,4 74% at 16
years reported by Elkins and associates,22 and 81% reported
at 12 years by de Kerchove and coworkers.23 Early reopera-
tions, which can occur with any surgical technique, gener-
ally reflect institutional learning curves (technical error),
whereas late reoperations highlight limitations inherent
with initially successful procedures. It is noteworthy that
most (12/18 in the present study), if not all, of the late rein-
terventions were required for autograft root pathol-
ogy.1,3,4,20-23 This resulted in disappointing freedom from
root reoperation that was not dissimilar from that seen in
other reports.1,4,22,23 Quite expectedly, the negative influ-
ence of root dilatation, root technique, and duration of fol-
low-up proved significant at multivariate analysis (Table
2), which is in agreement with prior work from our group,5
as well as most other groups.1,3,4,20,21,23Ross–Yacoub Procedure
The rationale for the Ross–Yacoub procedure lies in clin-
ical and basic research evidence. The strategy of repairing
dysfunctional autografts was inspired by the work of Elkins
and associates,22 who have since shown successful salvage
of autologous pulmonary valves in one fourth of Ross reop-
erations. Leading the concept further, several authors540 The Journal of Thoracic and Cardiovascular Surgreported anecdotal experience with remodeling of the auto-
graft root with valve preservation in the past 7 years,8-13
with the expectation of results similar to those reported for
native aortic aneurysms. Experience fromSievers and associ-
ates6 showing that subcoronary implants are immune from
dilatation at midterm follow-up lends theoretic support to
valve-sparing autograft remodeling because this can be
viewed as a late conversion to a ‘‘modified’’ subcoronary
Ross procedure. More importantly, basic research evidence
derived from studies on congenital heart disease, in which
the native pulmonary root works in the systemic circulation
since infancy, suggests that pulmonary vascular tissue never
truly remodels to resemble normal aortic vascular tissue.25
This casts serious doubts on the possibility that pulmonary
autograft roots, although viable, might ever function as nor-
mal aortic roots, even when the Ross procedure is performed
in young infants. Clinical observations on neoaortic root
dilatation being out of proportion with somatic growth in in-
fants and children support this hypothesis.24 On the contrary,
evidence is now available showing that the pulmonary valve
transplanted in the systemic circulation can remodel to re-
semble the structure of a normal aortic valve.26 One study
on explanted aneurysmal autografts, however, suggests that
this process might not always be able to preserve normal
mechanical properties.17 In summary, the autograft valve
leaflets might remodel toward an aortic phenotype, but the
autograft root will likely never do so.
The indication for autograft root reoperation is controver-
sial, particularly when valve dysfunction is absent or mild.
Conservative management of autograft root pathology, until
recently conceivable,5 appears narrow sighted in light of
available evidence on the progression of valve regurgitation
and, most importantly, on abrupt complications, such as dis-
section, which is reported in 5% of aneurysmal autografts
(Table 4).8-13,15-19,22,23 Based on these considerations, we
prospectively applied surgical indications, adopting the cri-
terion proposed by Svensson and colleagues14 for native
root pathology in patientswithMarfan syndrome and a bicus-
pid aortic valve. The choice was based on 2 considerations.
First, similar to Marfan syndrome and bicuspid aortic valve
roots, autografts dilate and might dissect. Second, histologic
changes in aneurysmal autografts are similar to those seen in
bicuspid aortic walls, as observed herein and by others.17ery c March 2010
TABLE 4. Overall experience with valve-sparing aortic root replacement after the Ross procedure
Reference
No. of
patients Age (y) Sex
Years s/p
Ross
Ross
technique
Autograft
dissection Technique
Outcome
(survived) Histology FU (y)
Sundt and coworkers,
20018
1 19 Male 7 Root – Yacoub 1 EF, CMN –
Ley and coworkers,
20029
1 39 Male 2.3 Root – David I 1 – 1.1
Schmidtke and coworkers,
200210
1 42 Male 10 Root – Yacoub 1 – 0.4
Ishizaka and coworkers,
200311
4 16.5  7.9 Male 4.0  2.9 Root – Yacoubþanuloplasty 4 EF, MPS 0.5  0.3
Masetti and coworkers,
200312
1 46 Male 12 Root – Yacoub 1 – 0.5
Nemoto and coworkers,
200415
1 2.5 Male 2 Ross/Konno – Repairþanuloplasty 1 – 0.5
Kincaid and coworkers,
200416
1 39 Male 6 Root 1 AARþRC sinus 1 CMN 0.33
Schoof and coworkers,
200617
2 30.6  10.5 Male 6.1 Root – NS 1 EF, SMC, F –
Watanabe and coworkers,
200618
1 38 Male 6 Root – David I 1 EF, CMN –
De Kerchove and
coworkers, 200923
7 – – 8.7 Root – David I 7 – 1.7  1.8
Luciani and coworkers,
present report
8 29.8  10.5 6 Male/2
female
9.2  2.7 Root 7,
inclusion 1
1/8 Yacoub 8 8 EF, SMC,
CMN
3.2  1.5
Overall valve-sparing
procedures
28 28.0  10.1 19 Male/2
female
7.4  2.5 27 Root,
1 inclusion
2/28 15 Yacoub
9 David
4 other
28/28 17/18 EF 1.9  1.3
FU, Follow-up; EF, elastin fragmentation/loss;CMN, cystic medial necrosis;MPS, mucopolysaccharide deposition; AAR, ascending aortic replacement;NS, not specified; RC, right
coronary; SMC, smooth muscle cell hypertrophy; F, fibrosis; NC, noncoronary sinus.
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103 reoperative procedures on the autograft root reported
during the last 12 years,4,8-12,15-23 28 (26%) resulted in pres-
ervation of the autologous pulmonary valve (Table 4). Re-
ports of valve-sparing operations were mostly anecdotal,
except for this study and 3 other series comprising 2 to 8 pa-
tients,11,20,23 with clinical and echocardiographic follow-up
exceeding 1 year in only this study and 2 other reports (over-
all average, 1.8  1.3 years; median, 0.5 years; range, 0.3–
4.6 years).9,23
Several techniques have been applied to autograft root re-
modeling, although the Yacoub procedure was the most
common (15 [54%] of 28 patients) and the one used in
the present series. Advantages of the Ross–Yacoub proce-
dure include avoidance of left and right ventricular outflow
tract adhesions, which can be tenacious; greater adaptability
to individual sinus anatomy, as suggested by Ishizaka and
coworkers11; and avoidance of Dacron prosthesis-to-auto-
graft leaflet contact by means of recreation of sinus of Val-
salva anatomy, which might cause abrasion of the thin
pulmonary valve leaflets. The same reasons are the ones,
we believe, that make adoption of the reimplantation tech-
nique (David I procedure) less desirable in this clinical set-
ting, although very recent reports have shown initial
success with the latter as well.9,18,23 One potential disad-The Journal of Thoracic and Cavantage of the Yacoub technique is the inability to stabilize
the annulus. However, prior evidence from our institution
has shown the latter to be less exposed to significant dila-
tion over time than the sinus portion,5 which is specifically
addressed by Yacoub-type remodeling. The present report
shows that systematic application of the Ross–Yacoub pro-
cedure can result in higher and satisfactory freedom from
prosthetic autograft valve replacement (97% vs 80% free-
dom from root reoperation), which is similar to what shown
with autograft valve repair by Brown and colleagues,20
Elkins and associates,22 and de Kerchove and coworkers.23
Variables associated with success of the Ross–Yacoub pro-
cedure, albeit marked by weak statistical power, recom-
mend surgical intervention in patients with convergent
aneurysm morphology and before the onset of relevant
valve insufficiency. Functional outcome and quality of
life after the Ross–Yacoub procedure are truly rewarding
and identical to those after the Ross procedure. This is per-
haps the most compelling argument in favor of a more com-
plex repair, which theoretically exposes patients to the risk
of future reoperation to a greater extent than composite aor-
tic root replacement. Indeed, analysis of worldwide experi-
ence confirms that the majority (74%) of autograft root
aneurysms have been dealt with by complete root replace-
ment, which represents a solid treatment modality.rdiovascular Surgery c Volume 139, Number 3 541
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ing the Ross procedure are those who have already traded
the risk of reintervention for superior quality of life (eg,
sports and pregnancy), and in our experience most of
them continue to do so, even when choosing options for re-
operation on the autograft root. In addition, experience is
now growing with percutaneous replacement of dysfunc-
tional homografts in patients undergoing the Ross proce-
dure: in the foreseeable future, transcatheter aortic valve
therapy, be it percutaneous or transapical,27 will also be
available for patients undergoing Ross and Ross–Yacoub
procedures with failing autografts. Although midterm valve
function was rewarding in the current study, one case of late
deterioration in the patient who had presented with acute
autograft dissection13 recommends caution in adopting the
Ross–Yacoub procedure in this setting. In addition, even
if the present is the largest clinical experience with this
strategy, it is also the one with the longest available fol-
low-up (Table 4). It is fair to state that root-remodeling op-
erations are complex, particularly in patients undergoing the
Ross procedure, and should be performed in centers with
vast experience. Elsewhere, composite autograft root re-
placement represents the safest option.Limitations of the Study
The present work shares the limitations inherent with any
retrospective nonrandomized study. In addition, the inde-
pendent effect of root and sinotubular junction remodeling
and the effect of earlier time of the Ross procedure were
not directly assessed. Furthermore, the number of autograft
root-remodeling operations performed to date, both at our
institution and worldwide, remains too small and follow-
up remains too short to define superiority over standard
root replacement.
In conclusion, extended follow-up after the Ross proce-
dure continues to show autograft root pathology as the
most common late complication. Strict patient selection
and avoidance of the root technique might reduce the prev-
alence of late dilatation. Elective pulmonary valve–sparing
root reoperation before significant valve regurgitation is as-
sociated with satisfactory midterm outcomes and quality of
life, allowing the Ross paradigm to live on.References
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